608 related articles for article (PubMed ID: 33005286)
1. Oral immunotherapy for peanut allergy: The pro argument.
Chinthrajah RS; Cao S; Dunham T; Sampath V; Chandra S; Chen M; Sindher S; Nadeau K
World Allergy Organ J; 2020 Aug; 13(8):100455. PubMed ID: 33005286
[TBL] [Abstract][Full Text] [Related]
2. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
3. Consensus report from the Food Allergy Research & Education (FARE) 2019 Oral Immunotherapy for Food Allergy Summit.
Pepper AN; Assa'ad A; Blaiss M; Brown E; Chinthrajah S; Ciaccio C; Fasano MB; Gupta R; Hong N; Lang D; Mahr T; Malawer E; Roach A; Shreffler W; Sicherer S; Vickers K; Vickery BP; Wasserman R; Yates K; Casale TB
J Allergy Clin Immunol; 2020 Aug; 146(2):244-249. PubMed ID: 32505612
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of alternatives to oral immunotherapy for food allergies.
Johnson-Weaver BT
Front Allergy; 2023; 4():1275373. PubMed ID: 37859977
[TBL] [Abstract][Full Text] [Related]
5. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
Scurlock AM
Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
[TBL] [Abstract][Full Text] [Related]
6. Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial.
Reier-Nilsen T; Carlsen KCL; Michelsen MM; Drottning S; Carlsen KH; Zhang C; Borres MP; Håland G
Pediatr Allergy Immunol; 2019 Sep; 30(6):638-645. PubMed ID: 31013372
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
[TBL] [Abstract][Full Text] [Related]
8. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial.
Anagnostou K; Islam S; King Y; Foley L; Pasea L; Bond S; Palmer C; Deighton J; Ewan P; Clark A
Lancet; 2014 Apr; 383(9925):1297-1304. PubMed ID: 24485709
[TBL] [Abstract][Full Text] [Related]
9. Quality of life of children aged 8-12 years undergoing food allergy oral immunotherapy: Child and parent perspective.
Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
Allergy; 2020 Oct; 75(10):2623-2632. PubMed ID: 32350869
[TBL] [Abstract][Full Text] [Related]
10. Current Status of Potential Therapies for IgE-Mediated Food Allergy.
Parrish CP; Har D; Andrew Bird J
Curr Allergy Asthma Rep; 2018 Feb; 18(3):18. PubMed ID: 29470658
[TBL] [Abstract][Full Text] [Related]
11. Oral immunotherapy for peanut allergy in clinical practice is ready.
Mansfield LE
Allergy Asthma Proc; 2013; 34(3):205-9. PubMed ID: 23676569
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life of Food-Allergic Patients Before, During, and After Oral Immunotherapy.
Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):429-436.e2. PubMed ID: 30129441
[TBL] [Abstract][Full Text] [Related]
13. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal.
Marrs T; Flohr C; Perkin MR
Br J Dermatol; 2015 Nov; 173(5):1125-9. PubMed ID: 26769642
[TBL] [Abstract][Full Text] [Related]
14. Oral Immunotherapy in Food Allergy: A Critical Pediatric Perspective.
Akarsu A; Brindisi G; Fiocchi A; Zicari AM; Arasi S
Front Pediatr; 2022; 10():842196. PubMed ID: 35273931
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy and biologics in the management of IgE-mediated food allergy: Systematic review and meta-analyses of efficacy and safety.
Riggioni C; Oton T; Carmona L; Du Toit G; Skypala I; Santos AF;
Allergy; 2024 May; ():. PubMed ID: 38747333
[TBL] [Abstract][Full Text] [Related]
16. Oral immunotherapy in food allergies: A practical update for pediatricians.
Sabouraud M; Biermé P; Andre-Gomez SA; Villard-Truc F; Corréard AK; Garnier L; Payot F; Braun C
Arch Pediatr; 2021 May; 28(4):319-324. PubMed ID: 33858732
[TBL] [Abstract][Full Text] [Related]
17. Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy.
Virkud YV; Burks AW; Steele PH; Edwards LJ; Berglund JP; Jones SM; Scurlock AM; Perry TT; Pesek RD; Vickery BP
J Allergy Clin Immunol; 2017 Mar; 139(3):882-888.e5. PubMed ID: 27609653
[TBL] [Abstract][Full Text] [Related]
18. [The clinical advances of the peanut oral immunotherapy].
Li W; Dong X; Liu GH
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 May; 55(5):592-597. PubMed ID: 34034398
[TBL] [Abstract][Full Text] [Related]
19. Oral immunotherapy for peanut allergy: The con argument.
Fiocchi A; Artesani MC; Fierro V; Riccardi C; Dahdah L; Mennini M
World Allergy Organ J; 2020 Aug; 13(8):100445. PubMed ID: 33664931
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
